A gonadotropin releasing hormone analogue prevents cyclical attacks of porphyria

Karl Anderson, Irving M. Spitz, C. Wayne Bardin, Attallah Kappas

Research output: Contribution to journalArticle

58 Citations (Scopus)

Abstract

• Acute Intermittent porphyria is a genetic disease in which endogenous hormones affect clinical expression. Premenstrual exacerbations can occur, sometimes often, in women with this disease. Gonadotropin releasing hormone analogues can prevent ovulation by reducing secretion of luteinizing hormone and follicle-stimulating hormone. In six patients with well-documented acute intermittent porphyria and frequent cyclical exacerbations, daily administration of an agonistic gonadotropin releasing hormone analogue, ([ImBzl]-D-His6,Pro9-NET)gonadotropin releasing hormone, intranasally or subcutaneously for as long as 26 months reduced or eliminated premenstrual attacks and caused only minor side effects. Adjustments in dosage or route of administration were sometimes needed. We conclude that endocrine manipulation by treatment with a gonadotropin releasing hormone agonist will prevent neurovisceral attacks of acute intermittent porphyria due to cyclical changes in endogenous hormones and is a safe alternative to exogenous steroids, which may induce attacks of this disease.

Original languageEnglish (US)
Pages (from-to)1469-1474
Number of pages6
JournalArchives of Internal Medicine
Volume150
Issue number7
StatePublished - Jul 1990

Fingerprint

Porphyrias
Acute Intermittent Porphyria
Gonadotropin-Releasing Hormone
Hormones
Inborn Genetic Diseases
Follicle Stimulating Hormone
Luteinizing Hormone
Ovulation
Steroids
Therapeutics

ASJC Scopus subject areas

  • Internal Medicine

Cite this

A gonadotropin releasing hormone analogue prevents cyclical attacks of porphyria. / Anderson, Karl; Spitz, Irving M.; Wayne Bardin, C.; Kappas, Attallah.

In: Archives of Internal Medicine, Vol. 150, No. 7, 07.1990, p. 1469-1474.

Research output: Contribution to journalArticle

Anderson, K, Spitz, IM, Wayne Bardin, C & Kappas, A 1990, 'A gonadotropin releasing hormone analogue prevents cyclical attacks of porphyria', Archives of Internal Medicine, vol. 150, no. 7, pp. 1469-1474.
Anderson, Karl ; Spitz, Irving M. ; Wayne Bardin, C. ; Kappas, Attallah. / A gonadotropin releasing hormone analogue prevents cyclical attacks of porphyria. In: Archives of Internal Medicine. 1990 ; Vol. 150, No. 7. pp. 1469-1474.
@article{b450548647e045219b5c770483bf4661,
title = "A gonadotropin releasing hormone analogue prevents cyclical attacks of porphyria",
abstract = "• Acute Intermittent porphyria is a genetic disease in which endogenous hormones affect clinical expression. Premenstrual exacerbations can occur, sometimes often, in women with this disease. Gonadotropin releasing hormone analogues can prevent ovulation by reducing secretion of luteinizing hormone and follicle-stimulating hormone. In six patients with well-documented acute intermittent porphyria and frequent cyclical exacerbations, daily administration of an agonistic gonadotropin releasing hormone analogue, ([ImBzl]-D-His6,Pro9-NET)gonadotropin releasing hormone, intranasally or subcutaneously for as long as 26 months reduced or eliminated premenstrual attacks and caused only minor side effects. Adjustments in dosage or route of administration were sometimes needed. We conclude that endocrine manipulation by treatment with a gonadotropin releasing hormone agonist will prevent neurovisceral attacks of acute intermittent porphyria due to cyclical changes in endogenous hormones and is a safe alternative to exogenous steroids, which may induce attacks of this disease.",
author = "Karl Anderson and Spitz, {Irving M.} and {Wayne Bardin}, C. and Attallah Kappas",
year = "1990",
month = "7",
language = "English (US)",
volume = "150",
pages = "1469--1474",
journal = "JAMA Internal Medicine",
issn = "2168-6106",
publisher = "American Medical Association",
number = "7",

}

TY - JOUR

T1 - A gonadotropin releasing hormone analogue prevents cyclical attacks of porphyria

AU - Anderson, Karl

AU - Spitz, Irving M.

AU - Wayne Bardin, C.

AU - Kappas, Attallah

PY - 1990/7

Y1 - 1990/7

N2 - • Acute Intermittent porphyria is a genetic disease in which endogenous hormones affect clinical expression. Premenstrual exacerbations can occur, sometimes often, in women with this disease. Gonadotropin releasing hormone analogues can prevent ovulation by reducing secretion of luteinizing hormone and follicle-stimulating hormone. In six patients with well-documented acute intermittent porphyria and frequent cyclical exacerbations, daily administration of an agonistic gonadotropin releasing hormone analogue, ([ImBzl]-D-His6,Pro9-NET)gonadotropin releasing hormone, intranasally or subcutaneously for as long as 26 months reduced or eliminated premenstrual attacks and caused only minor side effects. Adjustments in dosage or route of administration were sometimes needed. We conclude that endocrine manipulation by treatment with a gonadotropin releasing hormone agonist will prevent neurovisceral attacks of acute intermittent porphyria due to cyclical changes in endogenous hormones and is a safe alternative to exogenous steroids, which may induce attacks of this disease.

AB - • Acute Intermittent porphyria is a genetic disease in which endogenous hormones affect clinical expression. Premenstrual exacerbations can occur, sometimes often, in women with this disease. Gonadotropin releasing hormone analogues can prevent ovulation by reducing secretion of luteinizing hormone and follicle-stimulating hormone. In six patients with well-documented acute intermittent porphyria and frequent cyclical exacerbations, daily administration of an agonistic gonadotropin releasing hormone analogue, ([ImBzl]-D-His6,Pro9-NET)gonadotropin releasing hormone, intranasally or subcutaneously for as long as 26 months reduced or eliminated premenstrual attacks and caused only minor side effects. Adjustments in dosage or route of administration were sometimes needed. We conclude that endocrine manipulation by treatment with a gonadotropin releasing hormone agonist will prevent neurovisceral attacks of acute intermittent porphyria due to cyclical changes in endogenous hormones and is a safe alternative to exogenous steroids, which may induce attacks of this disease.

UR - http://www.scopus.com/inward/record.url?scp=0025276896&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0025276896&partnerID=8YFLogxK

M3 - Article

VL - 150

SP - 1469

EP - 1474

JO - JAMA Internal Medicine

JF - JAMA Internal Medicine

SN - 2168-6106

IS - 7

ER -